Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 179-185

  Liu, Mei Ying ^a,b   Shih, Ya Yi ^a   Chou, Sheng Ping ^a   Chen, Chien Jen ^c   Sheen, Tzung Shiahn ^a   Yang, Czau Siung ^a   Chen, Jen Yang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anti EBV BHRF1 antibody; Nasopharyngeal carcinoma

Indexed keywords

DEOXYRIBONUCLEASE; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY; PROTEIN BCL 2; RECOMBINANT PROTEIN; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EPSTEIN BARR VIRUS; ESOPHAGUS CANCER; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; OPEN READING FRAME; SEQUENCE HOMOLOGY; STOMACH CARCINOMA;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CAPSID; CAPSID PROTEINS; CLONING, MOLECULAR; DEOXYRIBONUCLEASES; EPSTEIN-BARR VIRUS INFECTIONS; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY; VIRAL PROTEINS;

DNA VIRUSES; ESCHERICHIA; HUMAN HERPESVIRUS 4; MIRIDAE;

EID: 0031671342     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<179::AID-JMV1>3.0.CO;2-4     Document Type: Article

References (32)

1. Allsopp TE, Wyatt S, Paterson HF, Davies AM (1993): The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307.
2. Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kou SL, Yang CS (1985): Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. Journal of Medical Virology 17:47-49.
3. Chen RL, Su IJ, Lin KH, Lee SH, Lin DT, Chuu WM, Lin KS, Huang LM, Lee CY (1991): Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis: An atypica form of Epstein-Barr virus infection. American Journal of Clinical Pathology 96:171-176.
4. Cleary ML, Smith SD, Sklar J (1986): Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
5. Dawson CW, Eliopoulos AG, Dawson J, Young LS (1995): BHRF1, a viral homologue of the bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 9:69-77.
6. de The G (1979): The epidemiology of Burkitt's lymphoma: Evidence for a causal relationship with Epstein-Barr virus. American Journal of Epidemiology 1:32-54.
7. Garcia I, Martinou I, Tsujimoto Y, Martinou JC (1992): Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 258:302-304.
8. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A (1993): Epstein-Barr virus-encoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proceedings of the National Academy of Sciences U.S.A. 90:8479-8483.
9. Henle G, Henle W (1966) Immunofluorescence in cells derived from Burkitt's lymphoma. Journal of Bacteriology 91:1248-1256.
10. Henle G, Henle W, Diehl V (1968): Relation of Burkitt's tumor associated herpes-type virus to infectious mononucleosis. Proceedings of the National Academy of Sciences U.S.A. 59:94-101.
11. Henle G, Henle W (1979): Epstein-Barr virus specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1-17.
12. Hickish T, Robertson D, Clarke P, Hill M, di Stefano F, Clarke C, Cunningham D (1994): Ultrastructural location of BHRF1: An Epstein-Barr virus gene product which has homology with bcl-2. Cancer Research 54:2808-2811.
13. Horner D, Lewis M, Farrell PJ (1995): Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38: 195-205.
14. Joab I, Nicolas JC, Schwaab G, de-The G, Clausse B, Perricaudet M, Zeng Y (1991): Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. International Journal of Cancer 48:647-649.
15. Lee MA, Yates JL (1992): BHRF1 of Epstein-Barr virus which is homologous to human proto-oncogene bcl-2, is not essential for transformation of B cells or for virus replication in vitro. Journal of Virology 66:1899-1906.
16. Marchini A, Tomkinson B, Cohen JI, Kieff E (1991): BHRF1, the Epstein-Barr virus gene with homology to bcl-2, is dispensable for B-lymphocyte transformation and virus replication. Journal of Virology 65:5991-6000.
17. Martel-Renoir D, Gruneward V, Touitou R, Schwaab G, Joab I (1995): Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. Journal of General Virology 76:1401-1408.
18. Newkirk MM, Shiroky JB, Johnson N, Danoff D, Isenberg DA, Shustik C, Pearson GR (1996): Rheumatic disease patients, prone to Sjogren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of bcl-2. British Journal of Rheumatology 35:1075-1081.
19. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB (1992): Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinoma. American Journal of Pathology 140:879-887.
20. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N (1993): Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. American Journal of Pathology 143:1063-1071.
21. Old LJ, Boyse EA, Oettgen HF, de Harven E, Geering G, Williamson B, Clifford P (1966): Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences U.S.A. 56:1699-1704.
22. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991): Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320-322.
23. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney SE, Goepfert H, Lanier PH, Hyams V, Moran E, Henle G, Henle W (1983): Applications of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 51:260-268.
24. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D, Kieff E (1987): Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161.
25. Pothen S, Cao T, Smith R, Levine PH, Levine A, Pearson GR (1993): Identification of T-and B-cell epitopes associated with a restricted component of the Epstein-Barr virus-induced early antigen complex. International Journal of Cancer 53:199-204.
26. Shanmugaratnam K (1982): Nasopharynx. In Schottenfeld D, Fraumeni JF Jr (eds): "Cancer epidemiology and prevention." Philadelphia: W.B. Saunders, pp 536-553.
27. Shapiro RS, McClain K, Frizzerr G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arther DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH (1988): Epstein-Barr virus-associated B-cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:234-243.
28. Studier FW, Moffat BA (1986): Useof bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. Journal of Molecular Biology 189:113-130.
29. Su IJ, Hsieh HC (1992): Clinicopathological spectrum of Epstein-Barr virus-associated T-cell malignancies. Leukemia and Lymphoma 7:47-53.
30. Tarodi B, Subramanian T, Chinnadurai G (1994): Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201: 404-407.
31. Towbin H, Staehelin T, Gorden J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences U.S.A. 76:4350-4354.
32. Vaux D, Cory S, Adams J (1988): Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.